TE

Tectonic Therapeutic, Inc.

TECX · Nasdaq

Tectonic Therapeutic, Inc. (TECX) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Tectonic Therapeutic, Inc. in 2026. The next earnings report is expected on November 5, 2026.

Earnings calendar

Next earnings date

05 Nov 2026

In 76 days

EPS estimate

-1.34

Revenue estimate

0

Past earnings

06 Aug 2026
EPS actual
-1.18 (+12.5%)
estimate -1.35
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
07 May 2026
EPS actual
-1.34 (-15.0%)
estimate -1.17
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
26 Feb 2026
EPS actual
-1.03 (+5.3%)
estimate -1.09
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Tectonic Therapeutic, Inc. beat consensus estimates in its latest earnings report, with EPS of $-1.18 and revenue of $0 that met estimates. In the prior report, EPS missed expectations while revenue met estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Alise S. Reicin
Employees
51
IPO date
21 Jun 2018
ISIN
US8789721086
Website
tectonictx.com

Frequently asked questions

When does Tectonic Therapeutic, Inc. (TECX) next report earnings?

Tectonic Therapeutic, Inc. (TECX) is scheduled to report earnings on November 5, 2026.

What was Tectonic Therapeutic, Inc.'s most recent earnings date?

Tectonic Therapeutic, Inc. (TECX) last reported earnings on August 6, 2026.

Where is Tectonic Therapeutic, Inc. stock listed?

Tectonic Therapeutic, Inc. (TECX) is listed on Nasdaq.